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Active Bacterial Core Surveillance (ABCs) Report
Emerging Infections Program Network
Neisseria meningitidis,  2001
ABCs Areas
California (3 county San Francisco Bay area); Colorado (5
county Denver area); Connecticut; Georgia; Maryland;
Minnesota; New York (15 county Rochester/Albany area);
Oregon; Tennessee (11 county area).
ABCs Population
The surveillance areas represent 36,033,178 persons.
Source: National Center for Health Statistics bridged-race
vintage 2001 postcensal file
ABCs Case Definition
Invasive meningococcal disease: isolation of Neisseria
meningitidis from normally sterile site in a resident of a
surveillance area in 2001. 
ABCs Methodology
Project personnel communicated at least monthly with contacts
in all microbiology laboratories serving acute care hospitals in
their area to identify cases.  Standardized case report forms
that include information on demographic characteristics,
clinical syndrome, and outcome of illness were completed for
each identified case.  Molecular subtyping was done on
meningococcal isolates at CDC.  Regular laboratory audits
assess  completeness of active surveillance and detect
additional cases.
  
All rates of  invasive meningococcal disease were calculated
using population estimates for 2001.  
For  national projections of cases, race- and age-specific rates
of disease were applied from the aggregate surveillance area
to the age and racial distribution of the 2001 U.S. population.
Cases with unknown race were distributed by area based on
reported race distribution for known cases within the eight age
categories.
Reported ABCs Profiles
Race No. (Rate*)
White 213 (0.8)
Black 68 (1.1)
Other 8 (0.4)
Total 289 (0.8)
Unknown race (n=45) distributed among knowns
*Cases per 100,000 population for ABCs areas.
Cases Deaths
Syndrome No. (%*) No. (Rate†)
Meningitis 138 (47.8) 11 (8.0)
Bacteremia w/o 114 (39.4) 16 (14.3)
*Percent of cases.  †Deaths per 100 cases with known outcome
Age
(years)
Serogroups 
B C Y Other
 No. (Rate*)  No. (Rate)  No. (Rate)  No. (Rate)
<1 22 (4.3) 3 (0.6) 6 (1.2) 3 (0.6)
1 8 (1.6) 2 (0.4) 0 (0.0) 2 (0.4)
2-4 12 (0.8) 6 (0.4) 3 (0.2) 5 (0.3)
5-17 13 (0.2) 15 (0.2) 9 (0.1) 7 (0.1)
18-34 26 (0.3) 16 (0.2) 9 (0.1) 12 (0.1)
35-49 13 (0.1) 7 (0.1) 13 (0.1) 7 (0.1)
50-64  4 (0.1) 9 (0.2) 11 (0.2) 5 (0.1)
>65 6 (0.1) 9 (0.2) 21 (0.5) 5 (0.1)
Total 104     (0.3)** 67 (0.2) 72 (0.2) 46 (0.1)
*Cases per 100,000 population for ABCs areas
**The rate of serogroup B disease excluding Oregon is 0.2 cases
per 100,000 population for ABC’a areas.
Rates of Meningococcal Disease in Adolescents
and Young Adults
Overall
Serogroups
C/Y/W-135
Serogroups
Age (years) No. (Rate*) No. (Rate)
14-17 20 (0.99) 14 (0.69)
18-22 36 (1.46) 14 (0.57)
*Cases per 100,000 population for ABCs areas
National Projection for Invasive Disease:
Cases:   1,975 (0.7/100,000)   
Deaths:    200 (0.1/100,000)
Healthy People 2010 Update:
Objective: Reduce the incidence of invasive meningococcal
disease to 0.9 per 100,000 population.
2010 Objective 2001 Rate*
0.9/100,000 0.7/100,000
*Cases per 100,000 U.S. population.
Source: ABCs/National Electronic Telecommunications
System for Surveillance (NETSS) 
For more information, visit our web site
http://www.cdc.gov/abcs
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